{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f2ae0b91ea7197e1ef08ed6/650de9849b2e780011e62f1e?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"This Week In XR September 22nd, 2023 ft. Michael Freeman, co-founder and CEO, Ocutrx","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5f2ae0b91ea7197e1ef08ed6/1695410086064-7faacea923e96348d78e4ef05104fe49.jpeg?height=200","description":"<p>This&nbsp;week we're musing about&nbsp;the sad fate of NFTs, the race to build AI co-pilots, Neuralink human trials, and the new Caleb Wood GenAI Star Wars fan scene. Our guest is Michael Freeman, co-founder of Ocutrx, which is launching an AR HMD, the Oculenz, that will help macular degeneration patients see.&nbsp;</p><p><br></p><p>Thank you to our sponsor, Zappar!</p><p><br></p><p>Don't forget to like, share, and follow for more! Follow us on all socials @ThisWeekInXR!</p><p><br></p><p><a href=\"https://www.youtube.com/redirect?event=video_description&amp;redir_token=QUFFLUhqbEpOQ1lBQjVNYWVWUE9EMU13NXhQd283NmRBZ3xBQ3Jtc0tuSnJZNVlmWm1wSER1NU9zUjB4UXpCMHhFYTUxSUJaQ0RoZV9KY0txQ1NOVXlULVp2YlRTNHJYemZhYW9wY1lpYlB5NW8zU0VRWS1XaTFZRk9SUGZLeTEzVVpkZTQ3Y0xJeU90VThzbmtLZV9zQURCRQ&amp;q=https%3A%2F%2Flinktr.ee%2Fthisweekinxr&amp;v=HjONfgOr0dA\" rel=\"noopener noreferrer\" target=\"_blank\">https://linktr.ee/thisweekinxr</a></p>","author_name":"Charlie Fink Productions"}